DV
Dividend Vision

CDNA — CareDx, Inc.

CareDx, Inc. (CDNA)

Total return is 400.8% over the past 12.1 years, 15.6 points ahead of SPY at 385.2%. Its deepest 1-year drawdown was 23.6%.

CareDx, Inc. is a single-stock equity security focused on molecular diagnostics and transplant monitoring solutions in the healthcare sector. The company does not currently pay distributions, making it oriented toward capital appreciation rather than income generation. This holding appeals primarily to growth-focused investors seeking exposure to the diagnostic testing and transplant care markets.

CDNA key facts

Asset type
Stock
Asset class
Equity
Inception date
07/17/2014
Distribution frequency
None
Last close
$45.32
Market cap
$2,344,594,944
Average volume
708800.0
Beta
2.419
Payout ratio
0.0
P/E ratio
21.7885
Forward P/E
25.4453
EPS
$2.08